Drug Type Herbal medicine  | 
Synonyms-  | 
Target-  | 
Action-  | 
Mechanism-  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePendingPhase 1/2  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Anxiety Disorders | Phase 2 | United States   | 01 Mar 2021 | |
| Arthritis, Reactive | Phase 2 | United States   | 01 Mar 2021 | |
| Bipolar Disorder | Phase 2 | United States   | 01 Mar 2021 | |
| COVID-19 | Phase 2 | United States   | 01 Mar 2021 | |
| Depressive Disorder | Phase 2 | United States   | 01 Mar 2021 | |
| Encephalomyelitis, Acute Disseminated | Phase 2 | United States   | 01 Mar 2021 | |
| Gastroesophageal Reflux | Phase 2 | United States   | 01 Mar 2021 | |
| Glomerulonephritis | Phase 2 | United States   | 01 Mar 2021 | |
| Guillain-Barre Syndrome | Phase 2 | United States   | 01 Mar 2021 | |
| Hepatitis | Phase 2 | United States   | 01 Mar 2021 | 





